Search hospitals > North Carolina > Huntersville

Novant Health Cancer Institute - Huntersville

Claim this profile
Huntersville, North Carolina 28078
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
33 reported clinical trials
7 medical researchers
Photo of Novant Health Cancer Institute - Huntersville in HuntersvillePhoto of Novant Health Cancer Institute - Huntersville in HuntersvillePhoto of Novant Health Cancer Institute - Huntersville in Huntersville

Summary

Novant Health Cancer Institute - Huntersville is a medical facility located in Huntersville, North Carolina. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Breast cancer, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Novant Health Cancer Institute - Huntersville is involved with conducting 33 clinical trials across 123 conditions. There are 7 research doctors associated with this hospital, such as Alan Skarbnik, MD, Kimberly S. Strickland, Obiageli U. Ogbata, and Kevin S. Roof.

Area of expertise

1Parotid Gland Cancer
Global Leader
Novant Health Cancer Institute - Huntersville has run 18 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II
2Breast Cancer
Global Leader
Novant Health Cancer Institute - Huntersville has run 13 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 positive
HER2 negative

Top PIs

Clinical Trials running at Novant Health Cancer Institute - Huntersville

Breast Cancer
Lung Cancer
Breast cancer
Parotid Gland Cancer
Testicular cancer
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Tumors
Ovarian Choriocarcinoma
Small Cell Lung Cancer
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Novant Health Cancer Institute - Huntersville?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security